Abstract
Cardiovascular disease is the leading cause of death worldwide and the second most common cause of death in Korea. Dyslipidemia is among the major modifiable risk factors for cardiovascular disease. To develop effective guidelines for the management of dyslipidemia, it is important to understand the epidemiologic characteristics of dyslipidemia in the target population. The prevalence of dyslipidemia in the Korean population has been reported variously from 30% to higher than 60%, but, in general, the prevalence of dyslipidemia among Koreans has been increasing. Among the subtypes of dyslipidemia, hypercholesterolemia and hyper-LDL cholesterolemia are relatively uncommon in Korea compared to other high-income countries. On the other hand, hypertriglyceridemia and hypo-HDL cholesterolemia are very common in Korea. Recent data shows that total and LDL cholesterol levels are increasing in the Korean population, while triglyceride and HDL cholesterol levels have not been changing. As a consequence, the prevalence of hypercholesterolemia and hyper-LDL cholesterolemia is increasing. These data reinforce the need to make a greater effort toward the prevention and treatment of dyslipidemia.
| Original language | English |
|---|---|
| Pages (from-to) | 352-357 |
| Number of pages | 6 |
| Journal | Journal of the Korean Medical Association |
| Volume | 59 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2016 May |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
}
Epidemiology of dyslipidemia in Korea. / Kim, Hyeon Chang.
In: Journal of the Korean Medical Association, Vol. 59, No. 5, 05.2016, p. 352-357.Research output: Contribution to journal › Review article
TY - JOUR
T1 - Epidemiology of dyslipidemia in Korea
AU - Kim, Hyeon Chang
PY - 2016/5
Y1 - 2016/5
N2 - Cardiovascular disease is the leading cause of death worldwide and the second most common cause of death in Korea. Dyslipidemia is among the major modifiable risk factors for cardiovascular disease. To develop effective guidelines for the management of dyslipidemia, it is important to understand the epidemiologic characteristics of dyslipidemia in the target population. The prevalence of dyslipidemia in the Korean population has been reported variously from 30% to higher than 60%, but, in general, the prevalence of dyslipidemia among Koreans has been increasing. Among the subtypes of dyslipidemia, hypercholesterolemia and hyper-LDL cholesterolemia are relatively uncommon in Korea compared to other high-income countries. On the other hand, hypertriglyceridemia and hypo-HDL cholesterolemia are very common in Korea. Recent data shows that total and LDL cholesterol levels are increasing in the Korean population, while triglyceride and HDL cholesterol levels have not been changing. As a consequence, the prevalence of hypercholesterolemia and hyper-LDL cholesterolemia is increasing. These data reinforce the need to make a greater effort toward the prevention and treatment of dyslipidemia.
AB - Cardiovascular disease is the leading cause of death worldwide and the second most common cause of death in Korea. Dyslipidemia is among the major modifiable risk factors for cardiovascular disease. To develop effective guidelines for the management of dyslipidemia, it is important to understand the epidemiologic characteristics of dyslipidemia in the target population. The prevalence of dyslipidemia in the Korean population has been reported variously from 30% to higher than 60%, but, in general, the prevalence of dyslipidemia among Koreans has been increasing. Among the subtypes of dyslipidemia, hypercholesterolemia and hyper-LDL cholesterolemia are relatively uncommon in Korea compared to other high-income countries. On the other hand, hypertriglyceridemia and hypo-HDL cholesterolemia are very common in Korea. Recent data shows that total and LDL cholesterol levels are increasing in the Korean population, while triglyceride and HDL cholesterol levels have not been changing. As a consequence, the prevalence of hypercholesterolemia and hyper-LDL cholesterolemia is increasing. These data reinforce the need to make a greater effort toward the prevention and treatment of dyslipidemia.
UR - http://www.scopus.com/inward/record.url?scp=84969760753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969760753&partnerID=8YFLogxK
U2 - 10.5124/jkma.2016.59.5.352
DO - 10.5124/jkma.2016.59.5.352
M3 - Review article
AN - SCOPUS:84969760753
VL - 59
SP - 352
EP - 357
JO - Journal of the Korean Medical Association
JF - Journal of the Korean Medical Association
SN - 1975-8456
IS - 5
ER -